DeepQure Announces Robust 3-Month Results from HERO-HTN Clinical Study at EuroPCR 2026 Written by PR Newswire Enable JavaScript and cookies to continueimage1.jpg?p=medium600#Read more http://www.prnasia.com/story/archive/4964050_CN64050_0